Skip to main content

Novo Nordisk A/S

Founders

Who Founded Novo Nordisk?

Hans Christian Hagedorn, Harald Pedersen · Founded 1989 · HQ today: Bagsvaerd, Denmark

Who founded Novo Nordisk?

Novo Nordisk was founded by Hans Christian Hagedorn, Harald Pedersen in 1989. It is now led by Maziar Mike Doustdar.

Founders
Hans Christian Hagedorn, Harald Pedersen
Founded
1989
Headquarters
Bagsvaerd, Denmark
Number of founders
2
Current CEO
Maziar Mike Doustdar (since 2025)
Where was Novo Nordisk founded?
Novo Nordisk was founded in Bagsværd, Denmark in 1989.
When was Novo Nordisk founded?
Novo Nordisk was founded in 1989.
Who started Novo Nordisk?
Novo Nordisk was founded by Hans Christian Hagedorn and Harald Pedersen.
How old is Novo Nordisk?
Novo Nordisk is 37 years old as of 2026.

Founding Story

In 1922 Danish Nobel laureate August Krogh and his wife Marie, a physician with diabetes, learned of the Toronto discovery of insulin and secured rights to produce it in Scandinavia. With physician Hans Christian Hagedorn they started Nordisk Insulinlaboratorium in 1923. Brothers Harald and Thorvald Pedersen, who had worked with Nordisk, left after a dispute and founded rival Novo Terapeutisk Laboratorium in 1925. The two companies competed for more than six decades before merging in 1989.

Background

Hans Christian Hagedorn was a pioneering Danish physician who co-founded the Nordisk Insulinlaboratorium in 1923. His defining moment was the development of the first prolonged-acting insulin formulations, which transformed insulin from a life-saving but short-acting emergency treatment into a manageable chronic therapy. This decision established the company's long-term philosophy of focusing on peptide chemistry and formulation science to improve patient compliance.

Role at Novo Nordisk A/S

Hans Christian Hagedorn (1888-1971) was a Danish physician who co-founded Nordisk Insulinlaboratorium in 1923 with August and Marie Krogh after the Kroghs obtained rights to make insulin in Scandinavia. In 1936 he showed that adding protamine slowed insulin absorption, which led to NPH (Neutral Protamine Hagedorn) insulin, a long-acting insulin still used today. Nordisk merged with rival Novo in 1989 to form Novo Nordisk. (Exact birth year remains publicly undisclosed).

Harald Pedersen

Co-founder 1925

Background

Harald Pedersen was a Danish machine maker who, with his brother Thorvald, a pharmacist, founded Novo Terapeutisk Laboratorium in 1925 after leaving Nordisk.

Role at Novo Nordisk A/S

Harald Pedersen and his brother Thorvald worked at Nordisk Insulinlaboratorium before a 1924 dispute led them to set up Novo Terapeutisk Laboratorium in Copenhagen in 1925. Harald designed the production equipment and the company's early insulin syringe, while Thorvald handled chemistry. Novo grew into a major insulin and enzyme producer and merged with Nordisk in 1989. (Exact birth year remains publicly undisclosed).

Novo Nordisk A/S: CEO & Leadership History

Full timeline →

Maziar Mike Doustdar

President and Chief Executive Officer

2025 – Present

Became CEO on August 7, 2025, succeeding Lars Fruergaard Jørgensen. Joined Novo Nordisk in 1992 and previously ran International Operations, where sales more than doubled over a decade. First non-Danish CEO in the company's history.

Lars Rebien Sørensen

Chair of the Board

2025 – Present

Serving as CEO from 2000 to 2016, he laid the absolutely critical, foundational R&D groundwork for GLP-1 agonists that would eventually lead to the massive global explosion of Ozempic and Wegovy.

Lars Fruergaard Jørgensen

Chief Executive Officer

2017 – 2025

CEO from January 2017 to August 2025. Oversaw the launches of Ozempic, Rybelsus and Wegovy and large capacity investments, then was replaced by the board in 2025 after share losses to Eli Lilly and a cut to guidance.

Lars Rebien Sørensen

Chief Executive Officer

2000 – 2016

Serving as CEO from 2000 to 2016, he laid the absolutely critical, foundational R&D groundwork for GLP-1 agonists that would eventually lead to the massive global explosion of Ozempic and Wegovy.

Compare Novo Nordisk A/S Leadership With Competitors

Keep researching Novo Nordisk

Who Founded Novo Nordisk? FAQ

Who were August and Marie Krogh and how did they secure the founding insulin rights in 1922?

August Krogh (1874 to 1949) was a Danish physiologist who won the 1920 Nobel Prize in Physiology or Medicine. In autumn 1922, during a US lecture tour, his wife Marie Krogh (a physician living with Type 1 diabetes) learned that Banting and Macleod in Toronto had discovered insulin; they traveled to Canada, secured permission to manufacture insulin in Scandinavia, and established Nordisk Insulinlaboratorium in Copenhagen in 1923 with Dr. H.C. Hagedorn.

Who was Dr. Hans Christian Hagedorn and what breakthrough did he make in insulin?

Dr. Hans Christian Hagedorn (1888 to 1971) was an effective Danish physician and co-founder of Nordisk. In 1936, Hagedorn discovered that adding protamine (a protein from trout sperm) to insulin prolonged its absorption, inventing NPH insulin (Neutral Protamine Hagedorn), the world's first long-acting insulin, which remains in widespread clinical use today.

Who were Harald and Thorvald Pedersen and how did they establish Novo Terapeutisk Laboratorium?

Harald Pedersen was an exceptionally skilled machine maker and inventor, and his brother Thorvald was a chemist who initially worked with Hagedorn. After a personal dispute in 1924, the Pedersen brothers broke away to found Novo Terapeutisk Laboratorium in 1925, engineering the 'Novo Syringe' and 'Insulin Novo'.

What was the well-known 65-year rivalry between Novo and Nordisk before the 1989 merger?

From 1924 until 1989, Novo and Nordisk operated as fierce competitors located just miles apart in Copenhagen, constantly competing to invent better insulins, purer extraction methods, and more precise injection devices, creating an intense Danish culture of world-leading diabetes innovation.

How did the founders pioneer the world's first modern insulin pen (NovoPen) in 1985?

In 1985, Novo transformed diabetes care by inventing the 'NovoPen', the world's first discreet, portable, pen-sized insulin delivery device with replaceable insulin cartridges, liberating diabetes patients from carrying glass vials, syringes, and sterilizing equipment.

How did August Krogh establish the non-profit foundation structure to protect Nordisk?

August Krogh and H.C. Hagedorn stipulated in Nordisk's 1926 royal charter that profits could never be distributed to private individuals, but must be permanently reinvested in medical research and public health, establishing the foundation charter that evolved into the Novo Nordisk Foundation.

What was Harald Pedersen's inventive clever in precision pharmaceutical machinery?

Harald Pedersen personally engineered custom glass-grinding machines, automated ampoule-filling tools, and high-precision testing apparatus in his workshop, establishing Novo's enduring reputation for leading manufacturing quality and device ergonomics.

What enduring spirit did the Danish founders bequeath to modern Novo Nordisk?

The founders bequeathed an uncompromising humanitarian commitment: that medical innovation must fundamentally relieve human suffering, maintain ultimate scientific rigor, and operate for the enduring benefit of society rather than mere financial speculation.

Related Founder Profiles

Compare founding stories, origins, and entrepreneurial journeys

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.